M L Zapp|M R Green - JoVE Visualize

Showing results (311-320 of 329) with videos related to

Pageof 33

Sort By:

Archives of Disease in Childhood|April 1, 1993

Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural historyM R Green, L T Weaver, A F Heeley, et al.

Seminars in Oncology|December 10, 1999

Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancerC M Rocha Lima, J R Eckardt, S S Leong, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999

High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.

Cell|December 9, 1998

Dissecting the regulatory circuitry of a eukaryotic genomeF C Holstege, E G Jennings, J J Wyrick, et al.

Nature|July 21, 1994

Nuclear protein CBP is a coactivator for the transcription factor CREBR P Kwok, J R Lundblad, J C Chrivia, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997

YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin geneB Guo, F Aslam, A J van Wijnen, et al.

Lung Cancer (Amsterdam, Netherlands)|September 1, 1996

A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B studyE P Mitchell, M C Perry, S D Luikart, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicityM A Socinski, C Zhang, J E Herndon, et al.

Cancer Research|February 1, 1990

Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibodyB A Parker, A B Vassos, S E Halpern, et al.

American Journal of Clinical Oncology|April 1, 1993

Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group BS D Luikart, M Goutsou, E D Mitchell, et al.

Pageof 33

Showing results (311-320 of 329) with videos related to

Sort By:

Pageof 33

Archives of Disease in Childhood|April 1, 1993

Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural historyM R Green, L T Weaver, A F Heeley, et al.

Seminars in Oncology|December 10, 1999

Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancerC M Rocha Lima, J R Eckardt, S S Leong, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999

High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.

Cell|December 9, 1998

Dissecting the regulatory circuitry of a eukaryotic genomeF C Holstege, E G Jennings, J J Wyrick, et al.

Nature|July 21, 1994

Nuclear protein CBP is a coactivator for the transcription factor CREBR P Kwok, J R Lundblad, J C Chrivia, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997

YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin geneB Guo, F Aslam, A J van Wijnen, et al.

Lung Cancer (Amsterdam, Netherlands)|September 1, 1996

A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B studyE P Mitchell, M C Perry, S D Luikart, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicityM A Socinski, C Zhang, J E Herndon, et al.

Cancer Research|February 1, 1990

Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibodyB A Parker, A B Vassos, S E Halpern, et al.

American Journal of Clinical Oncology|April 1, 1993

Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group BS D Luikart, M Goutsou, E D Mitchell, et al.

Pageof 33